Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristics
Weinberg, A.; Allshouse, A.A.; Mawhinney, S.; Canniff, J.; Benning, L.; Wentz, E.L.; Minkoff, H.; Young, M.; Nowicki, M.; Greenblatt, R.; Cohen, M.H.; Golub, E.T.
Journal of Acquired Immune Deficiency Syndromes 60(1): E15-E18
2012
ISSN/ISBN: 1944-7884 PMID: 22517417 DOI: 10.1097/qai.0b013e31824d30bdDocument Number: 535399
Document emailed within 0-6 h
Related Documents
Peters, P.James.; McNicholl, J.M.; Raengsakulrach, B.; Wasinrapee, P.; Mueanpai, F.; Ratanasuwan, W.; Intalapaporn, P.; Drobeniuc, J.; Ramachandran, S.; Thai, H.; Xia, G-Liang.; Kamili, S.; Khudyakov, Y.; Weidle, P.J.; Teo, C.Gee.; McConnell, M.S. 2013: An evaluation of hepatitis B virus diagnostic methods and responses to antiretroviral therapy among HIV-infected women in Thailand Journal of the International Association of Providers of Aids Care 12(5): 349-353Pippi, F.; Bracciale, L.; Stolzuoli, L.; Giaccherini, R.; Montomoli, E.; Gentile, C.; Filetti, S.; De Luca, A.; Cellesi, C. 2008: Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania HIV Medicine 9(7): 519-525
Pessoa, S.D.; Miyamoto, M.; Ono, E.; Gouvêa, A.íd.F.T.B.; de Moraes-Pinto, M.I.; Succi, R.C.M. 2010: Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART Vaccine 28(6): 1606-1612
Moreira, I.F.d.A.; Bianchini, M.P.; Moreira, G.R.C.; Almeida, A.M.; Rezende, B.A. 2020: Sexual function and metabolic/hormonal changes in women using long-term hormonal and non-hormonal contraceptives: a pilot study Bmc Women's Health 20(1): 240
Chasela, C.S.; Wall, P.; Drobeniuc, J.; King, C.C.; Teshale, E.; Hosseinipour, M.C.; Ellington, S.R.; Codd, M.; Jamieson, D.J.; Knight, R.J.; Fitzpatrick, P.; Kourtis, A.P.; Hoffman, I.F.; Kayira, D.; Mumba, N.; Kamwendo, D.D.; Martinson, F.; Powderly, W.; van der Horst, C.; Kamili, S.; Adair, L.; Ahmed, Y.; Ait-Khaled, M.; Albrecht, S.; Bangdiwala, S.; Bayer, R.; Bentley, M.; Bramson, B.; Bobrow, E.; Boyle, N.; Butera, S.; Chasela, C.; Chavula, C.; Chimerang'ambe, J.; Chigwenembe, M.; Chikasema, M.; Chikhungu, N.; Chilongozi, D.; Chiudzu, G.; Chome, L.; Cole, A.; Corbett, A.; Corneli, A.; Dow, A.; Duerr, A.; Eliya, H.; Ellington, S.; Eron, J.; Farr, S.; Ferguson, Y.O.; Fiscus, S.; Flax, V.; Fokar, A.; Galvin, S.; Guay, L.; Heilig, C.; Hoff 2012: Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 54(4): 318-320
Phuangchoei, P.; Chotiyaputta, W.; Chayakulkeeree, M. 2015: Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients Journal of the Medical Association of Thailand 98(3): 226-231
Wenderlein, J.M.; Nohlen, H.; Tauber, P.F. 1982: Acceptance of hormonal contraception versus intrauterine pessaries. Comparison of 515 women on hormonal contraceptives with 198 women using IUDs Münchener Medizinische Wochenschrift 124(51-52): 1147-1149
Ramos Paesa, C.; Arazo Garcés, P.; Pascual Catalán, A.; Hermida Lazcano, I.; Aguirre Errasti, J.M. 1998: Characteristics of chronic hepatitis C in patients infected by human immunodeficiency virus Revista Clinica Espanola 198(4): 207-211
Wang, P.; Lai, Z.; Tang, J.; Xu, W.; Mi, X.; Ma, F. 2000: Safety of hormonal steroid contraceptive use for hepatitis B virus carrier women Pharmacoepidemiology and Drug Safety 9(3): 245-246
Joshi, U.M.; Virkar, K.D.; Amatayakul, K.; Singkamani, R.; Bamji, M.S.; Prema, K.; Whitehead, T.P.; Belsey, M.A.; Hall, P.; Parker, R.A. 1986: Impact of hormonal contraceptives vis-à-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives Human Nutrition. Clinical Nutrition 40(3): 205-220
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Xu, H.-m.; Ren, H.; Peng, M.-l.; Ling, N.; Qing, Y.-l. 2003: A study of the characteristics of pre S/S gene mutation of hepatitis B virus (HBV) in mothers and HBV-infected children via mother-to-infant transmission Zhonghua Nei Ke Za Zhi 42(6): 388-391
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Chasela, C.S.; Kourtis, A.P.; Wall, P.; Drobeniuc, J.; King, C.C.; Thai, H.; Teshale, E.H.; Hosseinipour, M.; Ellington, S.; Codd, M.B.; Jamieson, D.J.; Knight, R.; Fitzpatrick, P.; Kamili, S.; Hoffman, I.; Kayira, D.; Mumba, N.; Kamwendo, D.D.; Martinson, F.; Powderly, W.; Teo, C.-G.; van der Horst, C.; Adair, L.; Ahmed, Y.; Ait-Khaled, M.; Albrecht, S.; Bangdiwala, S.; Bayer, R.; Bentley, M.; Bramson, B.; Bobrow, E.; Boyle, N.; Butera, S.; Chasela, C.; Chavula, C.; Chimerang'ambe, J.; Chigwenembe, M.; Chikasema, M.; Chikhungu, N.; Chilongozi, D.; Chiudzu, G.; Chome, L.; Cole, A.; Corbett, A.; Corneli, A.; Dow, A.; Duerr, A.; Eliya, H.; Ellington, S.; Eron, J.; Farr, S.; Owens Ferguson, Y.; Fiscus, S.; Flax, V.; Fokar, A.; Galvin, S.; Guay 2014: Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants Journal of Hepatology 60(3): 508-514
Eddy, R.K.; Chettle, N.J.; Wyeth, P.J. 1985: Antibody responses and virus reisolation in turkeys experimentally infected with an infectious bursal disease isolate Veterinary Record 116(14): 368-369
Rosenmund, A.; Camponovo, F.; Köchli, H.P. 1986: The effect of hormonal contraceptives and pregnancy on iron metabolism, plasma lactoferrin levels and granulocyte count in women Schweizerische Medizinische Wochenschrift 116(41): 1411-1414
Csatary, L.K.; Schnabel, R.; Bakács, T. 1999: Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine Anticancer Research 19(1b): 629-633
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455